<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>Ã§et disease (BD) is a rare, <z:hpo ids='HP_0011010'>chronic</z:hpo>, multisystemic, <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory disease</z:e> characterized by recurrent oral aphthous <z:mpath ids='MPATH_579'>ulcers</z:mpath>, <z:hpo ids='HP_0003249'>genital ulcers</z:hpo>, <z:hpo ids='HP_0000554'>uveitis</z:hpo>, and <z:mp ids='MP_0001212'>skin lesions</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Intestinal BD occurs in 10-15% of BD patients and shares many clinical characteristics with <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD), making differentiation of the 2 diseases very difficult and occasionally impossible </plain></SENT>
<SENT sid="2" pm="."><plain>The diagnosis of intestinal BD is based on clinical findings-as there is no pathognomonic laboratory test-and should be considered in patients who present with <z:hpo ids='HP_0002027'>abdominal pain</z:hpo>, <z:hpo ids='HP_0002014'>diarrhea</z:hpo>, <z:hpo ids='HP_0001824'>weight loss</z:hpo>, and <z:hpo ids='HP_0002573'>rectal bleeding</z:hpo> and who are susceptible to intestinal BD </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment for intestinal BD is similar to that for IBD, but overall prognosis is worse for intestinal BD </plain></SENT>
<SENT sid="4" pm="."><plain>Although intestinal BD is extremely rare in the United States, physicians will increasingly encounter these challenging patients in the future due to increased immigration rates of Asian and Mediterranean populations </plain></SENT>
</text></document>